BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29221719)

  • 1. Integration of different criteria for borderline resectable pancreatic cancer using classification tree analysis: the use of radiological tumour-vascular interface in correlation with surgical and pathological outcomes.
    Hwang JA; Jang KM; Kim SH; Kang TW; Song KD; Cha DI; Ahn S
    Clin Radiol; 2018 Mar; 73(3):321.e1-321.e10. PubMed ID: 29221719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Vessel Relationships in Pancreatic Ductal Adenocarcinoma at Multidetector CT: Different Classification Systems and Their Influence on Treatment Planning.
    Zaky AM; Wolfgang CL; Weiss MJ; Javed AA; Fishman EK; Zaheer A
    Radiographics; 2017; 37(1):93-112. PubMed ID: 27885893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic adenocarcinoma: the different CT criteria for peripancreatic major arterial and venous invasion.
    Li H; Zeng MS; Zhou KR; Jin DY; Lou WH
    J Comput Assist Tomogr; 2005; 29(2):170-5. PubMed ID: 15772532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative CT staging of borderline pancreatic cancer patients after neoadjuvant treatment: accuracy in the prediction of vascular invasion and resectability.
    Ahmed SA; Mourad AF; Hassan RA; Ibrahim MAE; Soliman A; Aboeleuon E; Elbadee OMA; Hetta HF; Jabir MA
    Abdom Radiol (NY); 2021 Jan; 46(1):280-289. PubMed ID: 32488556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the interface between retroperitoneal fat infiltration of pancreatic ductal carcinoma and the major artery by multidetector-row computed tomography: surgical outcomes and correlation with histopathological extension.
    Yamamoto Y; Shimada K; Takeuchi Y; Sofue K; Shibamoto K; Nara S; Esaki M; Sakamoto Y; Kosuge T; Hiraoka N
    World J Surg; 2012 Sep; 36(9):2192-201. PubMed ID: 22562451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
    Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hoshi N; Hirabayashi K; Ogata Y
    Eur J Surg Oncol; 2017 Jun; 43(6):1068-1075. PubMed ID: 28427822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant intraductal papillary mucinous neoplasm of the pancreas: in situ versus invasive carcinoma surgical resectability.
    Vullierme MP; Giraud-Cohen M; Hammel P; Sauvanet A; Couvelard A; O'Toole D; Levy P; Ruszniewski P; Vilgrain V
    Radiology; 2007 Nov; 245(2):483-90. PubMed ID: 17848678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma.
    Fukuda S; Oussoultzoglou E; Bachellier P; Rosso E; Nakano H; Audet M; Jaeck D
    Arch Surg; 2007 Feb; 142(2):172-9; discussion 180. PubMed ID: 17309969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applicability of current NCCN Guidelines for pancreatic adenocarcinoma resectability: analysis and pitfalls.
    Garces-Descovich A; Beker K; Jaramillo-Cardoso A; James Moser A; Mortele KJ
    Abdom Radiol (NY); 2018 Feb; 43(2):314-322. PubMed ID: 29392370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer.
    Nakao A; Kanzaki A; Fujii T; Kodera Y; Yamada S; Sugimoto H; Nomoto S; Nakamura S; Morita S; Takeda S
    Ann Surg; 2012 Jan; 255(1):103-8. PubMed ID: 22156923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borderline resectable pancreatic cancer: rationale for multidisciplinary treatment.
    Takahashi S; Kinoshita T; Konishi M; Gotohda N; Kato Y; Kinoshita T; Kobayashi T; Mitsunaga S; Nakachi K; Ikeda M
    J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):567-74. PubMed ID: 21331805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological and Radiological Splenic Vein Involvement are Predictors of Poor Prognosis and Early Liver Metastasis After Surgery in Patients with Pancreatic Adenocarcinoma of the Body and Tail.
    Mizumoto T; Toyama H; Asari S; Terai S; Mukubo H; Yamashita H; Shirakawa S; Nanno Y; Ueda Y; Sofue K; Tanaka M; Kido M; Ajiki T; Fukumoto T
    Ann Surg Oncol; 2018 Mar; 25(3):638-646. PubMed ID: 29264672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative assessment of peripheral vascular invasion of pancreatic ductal adenocarcinoma based on high-resolution MRI.
    Zhou X; Xu D; Wang M; Ma R; Song C; Dong Z; Luo Y; Wang J; Feng ST
    BMC Cancer; 2023 Nov; 23(1):1092. PubMed ID: 37950223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma?
    Marchegiani G; Andrianello S; Perri G; Secchettin E; Maggino L; Malleo G; Bassi C; Salvia R
    HPB (Oxford); 2018 May; 20(5):411-417. PubMed ID: 29191689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT criteria for venous invasion in patients with pancreatic head carcinoma.
    Phoa SS; Reeders JW; Stoker J; Rauws EA; Gouma DJ; Laméris JS
    Br J Radiol; 2000 Nov; 73(875):1159-64. PubMed ID: 11144792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial.
    Wittel UA; Lubgan D; Ghadimi M; Belyaev O; Uhl W; Bechstein WO; Grützmann R; Hohenberger WM; Schmid A; Jacobasch L; Croner RS; Reinacher-Schick A; Hopt UT; Pirkl A; Oettle H; Fietkau R; Golcher H
    BMC Cancer; 2019 Oct; 19(1):979. PubMed ID: 31640628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic ultrasonography complements computed tomography in predicting portal or superior mesenteric vein resection in patients with borderline resectable pancreatic carcinoma.
    Glazer ES; Rashid OM; Klapman JB; Harris CL; Hodul PJ; Pimiento JM; Malafa MP
    Pancreatology; 2017; 17(1):130-134. PubMed ID: 28043760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Dark-Blood Dual-Energy CT Images for Predicting Vascular Involvement and R0 Resection in Patients With Pancreatic Cancer.
    Si K; Wu H; Yang M; Guo Y; Zhang X; Ding C; Xue J; Han P; Li X
    AJR Am J Roentgenol; 2023 Jun; 220(6):838-848. PubMed ID: 36541594
    [No Abstract]   [Full Text] [Related]  

  • 20. "Shades of Gray" in pancreatic ductal adenocarcinoma: Reappraisals on resectability criteria: Debated indications for surgery in pancreatic cancer.
    Lombardi P; Silvestri S; Marino D; Santarelli M; Campra D; De Paolis P; Aglietta M; Leone F;
    Crit Rev Oncol Hematol; 2019 Jan; 133():17-24. PubMed ID: 30661653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.